Biosensis offers alpha-synuclein antibodies to support advancement in neuroscience and neurodegenerative disease research. Designed for precise recognition of full-length human and rodent α-synuclein, the antibodies exhibit null cross-reactivity with beta or gamma synuclein and are able to identify endogenous α-synuclein in human plasma.
They show high affinity for human α-synuclein, including A30P or A53T Parkinson’s associated mutations, thus extending applicability in Parkinson’s disease studies. They are also said to enhance significance in the domain of Alzheimer’s disease research.
Phone: 02 9698 2022
Amsbio StemFit Basic05 medium for scalable hPSC manufacturing
Compatible with both 2D adherent and 3D suspension culture, StemFit Basic05 enables a streamlined...
GeneTex carrier-free antibodies
GeneTex's carrier-fee antibodies are BSA-, sodium azide- and glycerol-free, featuring diverse...
Cayman Chemical LipidLaunch Ionizable Lipid LNP Screening Set
The LipidLaunch Ionizable Lipid LNP Screening Set is a screening set of 12 ionisable cationic and...
